Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Antiviral entities : Abbvie inc. save search
Oral Antiviral Market Report 2023: Demand for Novel Therapeutics Boosts Opportunities
Published: 2023-09-09 (Crawled : 04:20) - prnewswire.com
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
| Email alert
Add to watchlist
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
| Email alert
Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
report antiviral therapeutics market
The Global Antiviral Drugs Market to Exhibit Growth at a Paltry CAGR of ~4% by 2027 | DelveInsight
Published: 2023-02-02 (Crawled : 16:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.71%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.16%
H: 0.08%
C: -0.41%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.87%
H: 0.01%
C: -0.55%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.16%
H: 1.98%
C: 1.56%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -1.28%
H: 3.64%
C: 3.48%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: -0.75%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 0.62%
H: 2.22%
C: 1.94%
TNXP | $0.159 1.27% 1.26% 1.1M
|
Health Technology
|
| O: 0.85%
H: 5.08%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.44%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -1.95%
H: 0.16%
C: -1.18%
global antiviral growth market
Global Antiviral Therapies Market Anticipated to Gather $66,016.5 Million and Grow at 3.1% CAGR in the 2020-2027 Forecast Period [208-Pages] | Details by Research Dive
Published: 2023-01-27 (Crawled : 13:20) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.13%
H: 1.57%
C: 1.57%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.21%
H: 0.19%
C: -0.18%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.3%
C: -0.08%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.0%
H: 0.63%
C: -0.74%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.06%
H: 0.25%
C: -0.7%
research global antiviral market
Antiviral Drugs Market is expected to grow at a steady pace by 2027 | CAGR: 3.4% | UnivDatos Market Insights
Published: 2022-05-30 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
| Email alert
Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
antiviral expected market drug
Antiviral Drugs Market Size To Reach USD 50.02 BN In 2030 Due to Development Of New, Improved, And More Advanced Formulations, Such As Repurposed Drugs And Drug Combination Therapies, Says Reports and Data
Published: 2022-04-13 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.76%
H: 0.35%
C: 0.35%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: -0.83%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.12%
H: 0.44%
C: 0.17%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.24%
H: 0.45%
C: 0.39%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.24%
H: 0.53%
C: 0.18%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -1.38%
H: 0.0%
C: -3.67%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.02%
H: 0.8%
C: 0.71%
drug antiviral repurposed market
AbbVie and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19
Published: 2022-03-15 (Crawled : 13:30) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.11%
H: 2.74%
C: 2.38%
covid-19 treatment research covid collaboration antiviral
$ 19.89 Billion growth expected in Antiviral Drugs Market during 2021-2025 | AbbVie Inc., Bristol-Myers Squibb Co., and F. Hoffmann-La Roche Ltd. Emerge as Major Vendors | Technavio
Published: 2021-06-01 (Crawled : 01:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.44%
H: 0.26%
C: -1.31%
antiviral drug growth merge
$76.28 Billion Anti-Viral Therapies Market, 2027 - Growing Emphasis on Launching Anti-Viral Agents
Published: 2021-03-16 (Crawled : 11:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.02%
H: 0.76%
C: 0.57%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.08%
H: 1.42%
C: 1.23%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.08%
H: 1.3%
C: 0.91%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.28%
H: 1.03%
C: 0.81%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.27%
H: 1.52%
C: 1.22%
growing therapy antiviral
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.